PTCommunity News April 2018

INSYS Therapeutics Appoints Trudy Vanhove to Board of Directors
Novavax to Present Clinical Data on RSV F and NanoFlu™ Vaccines at World Vaccine Congress
Coherus BioSciences Management to Present at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco
Acology 10K Highlights Accomplishments, Looks Confidently Forward
Progressive Care Enters Into Definitive Agreements to Purchase the Pharmacy in Palm Beach County
Galectin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
Zosano Pharma to Host Conference Call to Provide Operational Update
Arizona Legislature Approves Hyperbaric Oxygenation Treatment for Veterans with Traumatic Brain Injury, Reports the Association of American Physicians and Surgeons (AAPS)
Oxford Performance Materials Announces Launch of OXPEKK®-LTS
Advantis Corp. Moves Forward With Pet Division
athenahealth Announces First Quarter 2018 Earnings Conference Call
Hemispherx Biopharma Announced Financial Results for the Year Ended December 31, 2017
Interpace Diagnostics Announces Coverage of Its Thyroid Assays by Blue Shield of California
MyoKardia Begins Dosing in Phase 2 MAVERICK-HCM Clinical Trial of Mavacamten in Symptomatic Non-obstructive Hypertrophic Cardiomyopathy Patients
Align Technology to Announce First Quarter 2018 Results on April 25, 2018
Argos Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights
Ascendis Pharma A/S Appoints Thomas A. Larson as Chief Commercial Officer
Marrone Bio Innovations to Present at The MicroCap Conference in New York on April 9th
SELLAS Life Sciences Announces Positive Interim Data from Phase 2b NeuVax™ (nelipepimut-S) Clinical Trial in Combination with Herceptin® in HER2 1+/2+ Breast Cancer Patients
UBM Americas’ Pharmaceutical Executive opens nominations for 2018 Emerging Pharma Leaders
Molina Healthcare Announces First Quarter 2018 Earnings Release and Conference Call Dates
Precision Therapeutics Reports Fiscal Year 2017 Financial Results
MacroGenics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Assembly Biosciences Appoints Jackie Papkoff, PhD, Senior Vice President, Chief Scientific Officer Microbiome
Microbix Announces Annual and Special Meeting Voting Results
Pacific Health Care Organization, Inc. Reports its 2017 Year-End Financial Results
TLC Announces Application with U.S. FDA for Proceeding of TLC590 as Investigational New Drug (IND)
REVA Initiates Commercial Distribution Partnership in Turkey
Operational Update
Inovalon Completes Previously Announced Acquisition of ABILITY Network
Spero Therapeutics Announces Fourth Quarter and Full Year 2017 Operating Results and Provides Pipeline Update
Aileron Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
Stratice Healthcare achieves Certification through the Allscripts Developer Program for eOrdersPlus
Byram Healthcare chooses eOrdersPlusTM Platform
Cancer Genetics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Strategic Business Updates
Illinois Rural Community Care Organization Selects Cerner HealtheIntent to Help Manage Medicare Claims for ACO
Aduro Biotech to Present at the H.C. Wainwright Annual Global Life Sciences Conference
Allscripts closes OneContent business to Hyland Software, Inc.
CohBar, Inc. Announces Fourth Quarter 2017 Financial Results
Daré Bioscience, Inc. Reports 2017 Financial Results and Provides Business Update
genedrive to premier its Genedrive® Hepatitis C test in Asia Pacific
Motif Bio Initiates NDA Rolling Submission for Iclaprim and Provides Business Update
DBV Technologies to Attend the 11th Kempen Life Sciences Conference
Sanofi: EMA to review cemiplimab as a potential treatment for advanced cutaneous squamous cell carcinoma
Sanofi: EMA to review Dupixent® (dupilumab) as potential treatment for inadequately controlled moderate-to-severe asthma
Fagron strengthens strategic position in USA through highly complementary acquisition of Humco
Probiodrug reports full year 2017 financial results
argenx to present complete data from the Phase 2 clinical trial of efgartigimod (ARGX-113) in myasthenia gravis at the American Academy of Neurology Annual Meeting
Veloxis Appoints Morten Marott as Chief Financial Officer
Shire plc : Rule 2.9 Announcement
Immunicum AB (publ) Provides Update on Ilixadencel Clinical Development Program
Publication of Biohit Oyj Annual Report 2017
HealthLynked Corp. Reports Fourth Quarter and Full Year 2017 Results, including 46% Revenue Growth in the Fourth Quarter of 2017
Transactions under Novozymes’ stock buyback program
C-RAD signs strategic agreement to equip ZON-PTC, a MAASTRO CLINIC company, in Maastricht, Netherlands for Catalyst PT
Shire plc : Director Declaration
RavenQuest Signs MOU to Acquire Western AgriPharma Limited
April 3, 2018 is Oncology Nursing Day
Status update of the Phase III ARAMIS clinical trial with darolutamide in patients with non-metastatic castration-resistant prostate cancer
BioPorto receives intention to grant for a divisional NGAL cutoff patent in Europe
Solon Eiendom ASA : Sales in Q1 2018
Pediapharm Announces the Commercial Launch of Cuvposa™ in Canada
Retrophin Initiates Pivotal Phase 3 Clinical Trial of Sparsentan for the Treatment of Focal Segmental Glomerulosclerosis
Imagin Medical Announces Private Placement
Delcath’s PHP Therapy to be Featured in Video Training Session at European Conference of Interventional Oncology
PositiveID Reports 2017 Results; Fourth Quarter Revenues Increase 47% Year Over Year
Treos Bio Names Gábor Illés as Its Chief Financial Officer
Status regarding Novo Nordisk's holding of its own shares (31 March 2018)
ChemoCentryx to Present at Two Upcoming Investor Conferences
Aeglea BioTherapeutics to Present New Phase 1/2 Trial Results in Arginase 1 Deficiency at the 2018 ACMG Annual Clinical Genetics Meeting
Selecta Biosciences to Present Updated Clinical Phase 2 Data of Lead Candidate SEL-212 at the Pan American League of Associations for Rheumatology (PANLAR) Congress on April 10, 2018
Aptose to Present at the H.C. Wainwright Annual Global Life Sciences Conference
Albireo Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Emerald Health Therapeutics Appoints Rebecca Wong as Vice President Quality Affairs
Poseida Raises $30.5 Million in Series B Financing
HTG Announces New Patent for Its Technology Issued in Japan
Cocrystal Pharma Receives FDA Clearance to Initiate Phase 2a Clinical Study Evaluating CC-31244 for the Treatment of Hepatitis C Virus
Tower One Wireless Acquires Mexico Tower Company With AT&T Master Lease Agreement
Cellectar Announces Issuance of U.S. Patent Covering CLR 131 Use in Multiple Myeloma
HealthEC Adds The Villages Health to Population Health Management Solution
Cesca Therapeutics Inc. Announces Release of X-Mini™ Cell Selection Kit for the CAR-T Research Market
Bellerophon Therapeutics to Provide Corporate Update at H.C. Wainwright Annual Global Life Sciences Conference
Symphony Health’s New Enhanced Views Program Expands Evidence-Driven Insights
Androvia LifeSciences Study Reveals New Evidence for Men Experiencing Fertility Problems
WellDoc Announces Providence Health & Services’ Implementation of BlueStar® Digital Therapeutic in a Pilot Program for Individuals with Type 2 Diabetes
Adamas Announces First Patient Enrolled in Phase 3 Trial of ADS-5102 in Multiple Sclerosis Patients with Walking Impairment
Canada House Announces Third Quarter Fiscal 2018 Results
Shire plc : Director/PDMR Shareholding
Progressive Care Releases Investor Presentation
Nova Leap Health Corp. Announces Execution of Definitive Agreement to Acquire Home Care Services Business in Eastern Canada, Anticipates Significant Increase in Revenues
NewLink Genetics Announces Participation at The H.C. Wainwright Annual Global Life Sciences Conference
ProLynx extends lead in half-life extension platform technology – Shows primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery system
AXIM Biotech Reaches Preliminary Agreement for Distribution of CanChew and MedChew Products Throughout South Korea
First Choice Healthcare Solutions Reports 2017 Results and Update on Strategic Partnership with Steward Health Care
BriaCell’s Lead Product Candidate Mechanism of Action Described in a Major Immunology Journal
Terveystalo Plc: Lääkäriasema ILO to become a part of Terveystalo
UroGen Pharma Announces Presentation of Results from Interim Analysis of Pivotal Phase 3 OLYMPUS Trial of UGN-101 (MitoGel™) for Non-Surgical Treatment of Upper Tract Urothelial Cancer (UTUC)
CURE Pharmaceutical Reports Strong Progress and Sets Growth Roadmap for Remainder of Year
Wildflower Secures $720,000 Purchase Order
Q-Centrix Solution Among First to Be Certified for CathPCI v5 Reporting
Ceapro Announces Acceptance of Abstract for Presentation at the Nutrition 2018 Meeting
N.M. Medical Cannabis Program Soars Past 50,000 Milestone
I-MED Pharma’s I-PEN® Receives Regulatory Approval from INVIMA in Colombia and ANMAT in Argentina
Announcement from Xbrane Biopharma's extra general meeting
Rezolute, Inc. Announces Close of Convertible Note Financing
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Essilor: Procedures for Requesting or Viewing Proxy Information for the Ordinary Annual Meeting on April 24, 2018
Ossur Hf : Transactions in relation to share buyback program
Nicox : Number of voting rights as of March 31, 2018
Nicox: Number of voting rights as of March 28, 2018
Philadelphia Media Network Ranks Tabula Rasa HealthCare No. 6 on 2018 Top Places to Work
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Zosano Announces Closing of Public Offering of Common Stock
Unum Therapeutics Announces Closing of Initial Public Offering and Concurrent Private Placement with Seattle Genetics
Curetis Receives U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge
EDAP TMS SA : EDAP Reports First US Cohort Study Results of Focal HIFU Prostate Ablation Shows Promising Outcomes
Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BeyondSpring Files Its 2017 Annual Report on Form 20-F
The Ensign Group Acquires Arizona Skilled Nursing Facility
The Cooper Companies Acquires The LifeGlobal Group, Expanding Fertility Solutions Portfolio
GBT Announces New Employment Inducement Grants
GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference
CEO Of Twinlab, Naomi Whittel’s Premier book, GLOW15, is an instant New York Times and Wall Street Journal bestseller
Nightstar Therapeutics Reports 2017 Financial Results and Business Highlights
New Patient-Centered Program Launched for New York Primary Care Practices

You are here

PTCommunity News April 2018